Skip to main content

Latest Market News — Page 117

Page 117 · 30 stories scored 7+ · newest 7:36 AM ET · How scores work

Fri, Aug 1430 stories
8BRUNBoost Run Inc.Boost Run Q2 Revenue Jumps 270% to $31.1M, Sees $400M ARR by Year-EndEarnings & guidance · Reuters▲ PositivePro7DGNXDiginex LtdDiginex Sets October 8 EGM to Approve $1.05B Resulticks AcquisitionM&A & partnerships · EQS▲ Positive7EDBLEdible Garden AG IncEdible Garden Posts $18.79 Q2 Loss Per Share Amid Cash CrunchEarnings & guidance · Dow Jones Newswires▼ Negative7BBIOBridgeBio Pharma, Inc.KKR Sells 5M BridgeBio Shares at $78 in Oversubscribed Secondary OfferingOwnership & investors · GlobeNewswire● Neutral7SLESuper League Enterprise, Inc.Super League Q2: Net Revenue Up 16%, Gross Margin Hits 41%, Cash at $6.7MEarnings & guidance · GlobeNewswire▲ Positive8IQSTiQSTEL InciQSTEL Posts Record $207M H1 Revenue, Guides to $8–$9M Adjusted EBITDA After Ultranet DealEarnings & guidance · PR Newswire▲ PositivePro7LTRNLantern Pharma Inc.Lantern Pharma Q2 Loss Narrows 25% as AI Spin-Off Takes ShapeEarnings & guidance · BusinessWire● Neutral7GLXYGalaxy Digital Inc.Galaxy Partners with Bank Leumi to Launch First Israeli Bank Digital Asset TradingM&A & partnerships · Reuters▲ Positive7HELPCybin Inc.Helus Pharma Posts Q1 FY27 Results, Flags Q4 Topline Data for Depression DrugEarnings & guidance · GlobeNewswire▲ Positive7ZVIAZevia PBCActivist Investor Pushes Zevia Sale at $2.75-$3.75 Per ShareM&A & partnerships · Reuters▲ Positive7BRUNBoost Run Inc.Boost Run Leases 20 MW GPU Capacity from 10X Capital, Plans 111 MW ExpansionM&A & partnerships · BusinessWire▲ Positive7AMPGAmpliTech Group, Inc.AmpliTech Q2 Loss Widens to $3.1M, Stock Plunges 26% PremarketEarnings & guidance · Benzinga▼ Negative7WDAYWorkday, Inc.Silver Lake-Workday Talks Spark Best Session Since 2016, Analysts See Sector FloorM&A & partnerships · Dow Jones Newswires▲ Positive8KRAKENKrakenKraken Parent Payward Posts 17% Revenue Growth, Broadens Beyond TradingEarnings & guidance · Dow Jones Newswires▲ PositivePro7ACXPAcurx Pharmaceuticals, Inc.Acurx Q2 Loss Narrows to $2.25M; FDA Path for Ibezapolstat AdvancesEarnings & guidance · PR Newswire● Neutral7CMCTCreative Media & Community Trust CorpCMCT Posts $4.03 Q2 Loss Per Share as Default Fallout MountsEarnings & guidance · Dow Jones Newswires▼ Negative7ANLAdlai Nortye Ltd.Adlai Nortye Reports H1 2026 Results, Pipeline Advances Across Pan-RAS ProgramsEarnings & guidance · GlobeNewswire▲ Positive7QNTMQuantum Biopharma Ltd.Quantum BioPharma Cuts Cash Burn 44%, Extends Runway to October 2027Earnings & guidance · GlobeNewswire▲ Positive7TVRDTvardi Therapeutics, Inc.Tvardi Posts Q2 Loss, Picks Ulcerative Colitis for Lead STAT3 DrugEarnings & guidance · GlobeNewswire● Neutral7NMRANeumora Therapeutics, Inc.Neumora Names New CEO, Extends Cash Runway to Q3 2027, and Sets Key Pipeline MilestonesEarnings & guidance · GlobeNewswire● Neutral7CORZCore Scientific, Inc.Core Scientific Closes Polaris DS Deal, Targets 1.5 GW Muskogee ExpansionM&A & partnerships · Dow Jones Newswires▲ Positive7AMPGAmpliTech Group, Inc.AmpliTech Q2 Loss Widens to $3.1M, Revenue Drops 26%Earnings & guidance · Dow Jones Newswires▼ Negative8ACCOACCO BRANDS CorpACCO Brands to Acquire Trust in Strategic ExpansionM&A & partnerships · Dow Jones Newswires● NeutralPro7RNTXRein Therapeutics, Inc.Rein Therapeutics Q2: Cash Runway to Q1 2028, IPF Trial Enrollment Ahead of ScheduleEarnings & guidance · GlobeNewswire● Neutral7ZNTLZentalis Pharmaceuticals, Inc.Zentalis Offering Priced at $3.50, Stock Slides 12% PremarketFinancing · Dow Jones Newswires▼ Negative9CAPRCapricor Therapeutics, Inc.FDA Agrees to Review New Duchenne Drug Data, Capricor Shares DoubleProduct & regulatory · Reuters▲ PositivePro9DGNXDiginex LtdDiginex Cuts Resulticks Deal to $1.05B, Targets October CloseM&A & partnerships · GlobeNewswire● NeutralPro7SPCXSPACE EXPLORATION TECHNOLOGIES CORPSpaceX Faces Second Share Unlock and New $1B Rocket RivalOwnership & investors · Dow Jones Newswires● Neutral8AMATApplied Materials, Inc.Applied Materials Posts Record Margins, Sees 'Unprecedented Visibility' Into 2027Earnings & guidance · Benzinga▲ PositivePro7KDKKodiak AI, Inc.Kodiak AI Wins California DMV Permit to Test Autonomous TrucksProduct & regulatory · GlobeNewswire▲ Positive
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.